Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Richardson PG. Melflufen-a novel agent in the treatment of relapsed/refractory multiple myeloma. US Oncol Hematol Rev. 2020;16(1):12–4.
2. Mateos MV, Bladé J, Bringhen S, et al. Melflufen: a peptide-drug conjugate for the treatment of multiple myeloma. J Clin Med. 2020;9(10):1–16.
3. Hitzerd SM, Verbrugge SE, Ossenkoppele G, et al. Positioning of aminopeptidase inhibitors in next generation cancer therapy. Amino Acids. 2014;46(4):793–808.
4. Nanus DM. Of peptides and peptidases: the role of cell surface peptidases in cancer. Clin Cancer Res. 2003;9(17):6307–9.
5. Lehmann F, Wennerberg J. Evolution of nitrogen-based alkylating anticancer agents. Processes. 2021;9(377):1–10.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献